• Info
  • Insider Ownership

Insider Trading & Ownership of Eric I. Richman

Location
Potomac, MD
Summary
The estimated net worth of Eric I. Richman is at least $1,402,400 dollars as of 25 Jun 2025. Eric I. Richman is the Director of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $1.26M. Eric I. Richman is the Director of NeuBase Therapeutics, Inc. and owns shares of NeuBase Therapeutics, Inc. stock worth about $139.6K.
Signature
/s/ Eric I. Richman
All Insider Reports
All Insider Reports

Notify me when Eric I. Richman files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Eric I. Richman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GANX Gain Therapeutics, Inc. Director $1,262,803 24 Jun 2025
NBSE NeuBase Therapeutics, Inc. Director $139,597 09 Sep 2022

Insider Transactions Reported by Eric I. Richman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.